Examining the presence of sarcopenia in women with rheumatoid arthritis: Case-control study

1 ALETAHA D, NEOGİ T, SİLMAN AJ, FUNOVİTS J, FELSON DT, BİNGHAM III CO, ET AL. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62(9): 2569-2581. Search in Google Scholar

2 GRAVALLESE EM, FİRESTEİN GS. Rheumatoid Arthritis - Common Origins, Divergent Mechanisms. N Engl J Med. 2023;388(6):529-542. Search in Google Scholar

3 SCHERER HU, HAUPL T, BURMESTER GR. The etiology of rheumatoid arthritis. J Autoimmun. 2020; 110: 102400. Search in Google Scholar

4 YANG J, LI Q. Rheumatoid Arthritis. N Engl J Med. 2023;388(20):1919. Search in Google Scholar

5 ALIVERNINI S, FIRESTEIN GS, McINNES IB. The pathogenesis of rheumatoid arthritis. Immunity. 2022;55(12):2255-2270. Search in Google Scholar

6 YUAN S, LARSSON SC. Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism. 2023;144:155533. Search in Google Scholar

7 VOGELE D, OTTO S, SOLLMANN N, HAGGENMÜLLER B, WOLF D, BEER M, SCHMİDT SA. Sarcopenia - Definition, Radiological Diagnosis, Clinical Significance. Rofo. 2023;195(5):393-405. Search in Google Scholar

8 CRUZ-JENTOFT AJ, BAEYENS JP, BAUER JM, BOİRİE Y, CEDERHOLM T, LANDİ F, ET AL. European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39: 412-423. Search in Google Scholar

9 WU D, LUO Y, LI T, ZHAO X, LV T, FANG G, et al. Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment. Front Immunol. 2022 Dec 22;13:1051082. Search in Google Scholar

10 BANO G, TREVİSAN C, CARRARO S, ET AL. Inflammation and sarcopenia: A systematic review and meta-analysis. Maturitas. 2017; 96: 10-15. Search in Google Scholar

11 RALL LC, ROUBENOFF R. Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions Rheumatology. 2004; 43(10): 1219-23. Search in Google Scholar

12 NGEULEU A, ALLALİ F, MEDRARE L, MADHİ A, RKAİN H, HAJJAJ-HASSOUNİ N. Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors. Rheumatol Int. 2017; 37(6): 1015-1020. Search in Google Scholar

13 BAHAT G, TUFAN A, TUFAN F, KİLİC C, AKPİNAR TS, KOSE M, ET AL. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr. 2016; 35(6): 1557-63. Search in Google Scholar

14 ROBERTS HC, DENİSON HJ, MARTİN HJ, PATEL HP, SYDDALL H, COOPER C, SAYER AA. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011; 40(4): 423-9 Search in Google Scholar

15 TRUDELLE-JACKSON E, JACKSON AW, FRANKOWSKİ CM, LONG KM, MESKE NB. Interdevice Reliability and Validity Assessment Of The Nicholas Hand-Held Dynamometer. J Orthop Sports Phys Ther. 1994; 20: 302-6. Search in Google Scholar

16 FRİES JF, SPİTZ PW, YOUNG DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol. 1982;9(5):789-93. Search in Google Scholar

17 VLAEYEN JWS, KOLE-SNİJDERS AMJ, ROTTEVEEL AM, ET AL. The role of fear of movement/(re)injury in pain disability. J Occup Rehab. 1995; 5(4): 235-252. Search in Google Scholar

18 KUMBAROĞLU FB, KARAKAYA KARABULUT J, APRAŞ BİLGEN Ş, ÜNAL E. Determination of the validity, reliability, and sensitivity of the BETY- Biopsychosocial Questionnaire in patients with a diagnosis of rheumatoid arthritis. JETR. 2021; 8(1): 90-98. Search in Google Scholar

19 WARE JE JR, SHERBOURNE CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30 (6): 473-83. Search in Google Scholar

20 TEKGOZ E, COLAK S, OZALP ATES FS, SONAEREN I, YİLMAZ S, CİNAR M. Sarcopenia in rheumatoid arthritis: Is it a common manifestation? Int J Rheum Dis. 2020; 23(12): 1685–1691. Search in Google Scholar

21 AMİNOV K. Sarcopenia and osteoporosis in patients with rheumatoid arthritis. Ann Rheum Dis. 2017; 76: 1351 Search in Google Scholar

22 REİNA D, GÓMEZ-VAQUERO C, DÍAZ-TORNÉ C, SOLÉ JMN. Assessment of nutritional status by dual X-Ray absorptiometry in women with rheumatoid arthritis: A case-control study. Medicine (Baltimore). 2019; 98(6): e14361. Search in Google Scholar

23 DAO HH, DO QT, SAKAMOTO J. Abnormal body composition phenotypes in Vietnamese women with early rheumatoid arthritis. Rheumatology. 2011; 50(7): 1250-8. Search in Google Scholar

24 DOĞAN SC, HİZMETLİ S, HAYTA E, KAPTANOĞLU E, ERSELCAN T, GÜLER E. Sarcopenia in women with rheumathoid arthritis. Eur J Rheumatol. 2015; 2(2): 57–61. Search in Google Scholar

25 ALKAN-MELİKOĞLU M. Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis. Arch Rheumatol. 2017; 32(1): 53-59. Search in Google Scholar

26 TADA M, YAMADA Y, MANDAİ K, HİDAKA N. Matrix metalloprotease 3 is associated with sarcopenia in rheumatoid arthritis-results from the CHIKARA study. Int J Rheum Dis. 2018; 21(11): 1962-1969. Search in Google Scholar

27 KEEFE FJ, SMİTH SJ, BUFFİNGTON AL, ET AL. Recent advances and future directions in the biopsychosocial assessment and treatment of arthritis. J Consult Clin Psychol. 2002; 70(3): 640-655. Search in Google Scholar

28 UHLİG T, LOGE JH, KRİSTİANSEN IS, ET AL. Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population. J Rheumatol. 2007; 34(6): 1241-1247. Search in Google Scholar

29 LEE MK, JEONG HH, KİM MJ, RYU H, BAEK J, LEE B. Nutrients against Glucocorticoid-Induced Muscle Atrophy. Foods. 2022;11(5):687. Search in Google Scholar

30 HEIN TR, PETERSON L, BARTIKOSKI BJ, PORTES J, ESPIRITO SANTO RC, XAVIER RM. The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis. Arthritis Res Ther. 2022;24(1):171. Search in Google Scholar

31 YAMADA Y, TADA M, MANDAI K. HIDAKA N, INUI K, NAKAMURA H. Glucocorticoid use is an independent risk factor for developing sarcopenia in patients with rheumatoid arthritis: from the CHIKARA study. Clin Rheumatol. 2020;39:1757–1764. Search in Google Scholar

32 MOSCHOU D, KRIKELIS M, GEORGAKOPOULOS C, MOLE E, CHRONOPOULOS E, TOURNIS S, et al. Sarcopenia in Rheumatoid arthritis. A narrative review. J Frailty Sarcopenia Falls. 2023;8(1):44-52. Search in Google Scholar